Workout
Healthy Eating
Meditation
Podcast
Authenticity
Social Service
About Us
Review Board
Editorial Process
Contact Us
Health Tracker
AI Tools
✔Fact Checked

Aston Villa closes the deal for the 21-year-old Spanish right-back

After weeks of being linked with a variety of Spanish right-backs, Aston Villa appear to have taken their option. Levante right-back Andrés García will be their next signing, according to multiple reports.

García, 21, has been in good form for Levante this season, starting all 22 of their games in the Segunda. He also has 3 goals and 3 assists to his name so far. Relevo reports that Aston Villa has reached a €7 million deal for García, which could increase by €2 million in variables and will see the Valencian team retain a 15% sell-on clause.

Sporting CP and Real Betis were interested in García, but Villa’s offer far exceeds theirs, so he will head to Birmingham. Levante had wanted to keep him on loan for the rest of the season, but the move will be immediate, with García set for a significant salary increase.

Villa had been linked to players such as Celta Vigo’s Oscar Mingueza and Rayo Vallecano’s Andrei Ratiu, with release clauses of €20 million and €25 million respectively. It will also be a blow for Barcelona, ​​​​who were hoping to earn €10 million from their own 50% sell-on clause in Mingueza’s contract and thus finance some business in January.

Last reviewed on

Expert Q&A

Ask a Question
Share Now:

Was this article helpful?

🤓

😕

dotdash removebg preview

FitToFar is part of the Dotdash Meredith publishing family.

Please review our updated Terms of Service.

BE THE FIRST TO KNOW

SUBSCRIBE TO GET LATEST FITNESS AND NUTRITION UPDATES!

We don’t spam! Read our privacy policy for more info.

The FitToFar News team takes pride in providing readers with accurate, properly sourced, and objectively analyzed content. Each news piece is stringently fact-checked by our Integrity Network, and any form of plagiarism or malicious behavior from our authors and contributors is strictly forbidden.

Our articles follow a number of key standards:

  • Each cited research and studies should come from renowned peer-reviewed journals or educational bodies. Additionally, any quoted data and figures must be traceable to its origin, while also detailing their significance.

  • Content related to treatment, medicine, and procedure must plainly specify availability, cost, possible side effects, targets, possible interactions, and unapproved usage (if relevant).

  • Every news article should have inputs from at least two authorized professionals, with corresponding qualifications and ties to appropriate associations or works.

  • The reader must be made aware of any potential conflict of interest relating to the source or study.

  • Finally, all news pieces should be supplied with enough background and context regarding the relevant topic or condition.